| Revenue growth | 6% YoY in FY26 to ₹88.5cr. |
|---|---|
| Margins | EBITDA margins improved to 37.5%; sustainable around 35-40%. |
| Demand visibility | Strong B2C demand; B2G stability via government contracts. |
| Management confidence | High for FY27/28 after resolving regulatory hurdles. |
Growth
FY26 Revenue grew 6% YoY; EBITDA increased 17% to ₹33.2cr; PAT rose 21%. Margins expanded by 330bps to 37.5%.
Outlook
Guided 25-30% growth for FY27/28; FY27 Capex ₹20-25cr; targets revenue of ₹110-120cr for FY28.
Risks
Regulatory delays (PNDT/AERB) impacted project timelines; long receivable cycles from government B2G contracts.
Earnings Call filed with BSE, BSE: 544482. Summary written with AI assistance from the document.
Star Imaging and Path Lab Ltd: key numbers
- Share price
- ₹77.70
- Market cap
- ₹135.3 Cr
- Revenue (annual)
- ₹88.53 Cr
- Net profit (annual)
- ₹19.28 Cr
- P/E (TTM)
- 7.0×Sector 57.8×
- Promoter holding
- 71.92%
- FII holding
- 0.61%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Star Imaging and Path Lab Ltd
All →Star Imaging and Path Lab Earnings Call: Key Takeaways
Star Imaging reported steady FY26 growth despite regulatory delays in new centers. Management shifted focus to FY27, banking on a capacity ramp-up and improved government receivables to drive momentum.
Star Imaging and Path Lab Earnings Call: Key Takeaways
Star Imaging reports FY26 revenue of ₹88.5cr (+6% YoY) and PAT of ₹19.3cr (+21% YoY). Strategy focuses on PPP models and expanding B2B networks.
Star Imaging and Path Lab H2 FY26 Results: Net Profit ₹9.2 Cr, Down 5.2% YoY
Star Imaging and Path Lab Ltd reported revenue from operations of ₹43.3 Cr (+5.9% YoY) and net profit of ₹9.2 Cr (-5.2% YoY) for H2 FY26.
- Key figure
- Net profit ₹9.2 Cr · -5.2% YoY